(Q35089537)

6 August 2017

title

Gene therapy of lung adenocarcinoma using herpes virus expressing a fusogenic membrane glycoprotein (English)

1 reference

6 August 2017

0 references

Bing Zhu

1

1 reference

6 August 2017

Jian-ru Yang

2

1 reference

6 August 2017

Yue-quan Jiang

3

1 reference

6 August 2017

Shi-feng Chen

4

1 reference

6 August 2017

Xin-ping Fu

5

1 reference

6 August 2017

publication date

1 July 2014

1 reference

Cell Biochemistry and Biophysics

6 August 2017

published in

1 reference

6 August 2017

volume

69

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

583-587

1 reference

Potent antitumor activity after systemic delivery of a doubly fusogenic oncolytic herpes simplex virus against metastatic prostate cancer

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-9836-4

Effective treatment of pancreatic cancer xenografts with a conditionally replicating virus derived from type 2 herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-9836-4

Multiple applications for replication-defective herpes simplex virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-9836-4

Inhibition of NF-kappaB in fusogenic membrane glycoprotein causing HL-60 cell death: implications for acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-9836-4

The herpes simplex virus type 1 locus that encodes the latency-associated transcript enhances the frequency of encephalitis in male BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-9836-4

Sequence-based methods for identifying epidemiologically linked herpes simplex virus type 2 strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-9836-4

10.1007/S12013-014-9836-4

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference